An evaluation of Thailand smoking cessation service program on clinical outcomes for public policy: Protocol for a multicenter prospective observational study
More details
Hide details
School of Pharmacy, Monash University Malaysia, Subang Jaya, Malaysia
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada
The Ottawa Methods Center, Ottawa Research Institute, The Ottawa Hospital, Ottawa, Canada
Thai Health Professional Alliance Against Tobacco, Bangkok, Thailand
Faculty of Medicine, Srinakharinwirot University Ongkarak, Nakornnayok, Thailand
Diabetes Mellitus and Endocrine Center, Paolo Phaholyothin Hospital, Bangkok, Thailand
Department of Pharmacotherapy, College of Pharmacy, The University of Utah, Salt Lake City, United States
Publication date: 2021-09-02
Corresponding author
Chayutthaphong Chaisai   

School of Pharmacy, Monash University Malaysia, Subang Jaya, Malaysia
Tob. Induc. Dis. 2021;19(Suppl 1):A176
Tobacco smoking is the most common preventable cause of morbidity and mortality in the world. The number of individuals who continue to smoke remains high, and 80 percent of tobacco smokers live in low-and middle-income countries (LMIC). Preventing and reducing the number of new smokers as well as helping current smokers to quit smoking is an important global agenda. The SMART Quit Clinic Program (FAHSAI Clinic) provides smoking cessation services to Thai smokers by a multidisciplinary team. To date, 552 FAH-SAI Clinics across all 77 provinces of Thailand have been established. Although FAHSAI Clinic was launched in 2010, the effectiveness and cost-effectiveness of the program have never been formally evaluated.

We aim to assess the real-world effectiveness of a smoking cessation service program in Thailand in terms of program performance, clinical outcomes, and the program’s cost-effectiveness to generate evidence for public policy and improve the service model.

A multicenter prospective observational study will be performed. This study will focus on 24 FAH-SAI clinics across 21 provinces of Thailand. The primary outcomes are 7-day point prevalence abstinence and continuous abstinence rate (CAR) at 3, 6, and 12 months. The secondary outcomes are the association of socio-demographic and disease-related factors at 3, 6, and 12 months smoking CAR. The outcomes will be measured using two measurement methods: self-reports and exhaled carbon monoxide.

This study will be the first that reports the real-world effectiveness and cost-effectiveness of a well-established smoking cessation program in Thailand. This study does not include a control group, so care in interpreting its results is vital. Findings from this study can help improve the quality of smoking cessation services by FAHSAI clinics and other smoking cessation services, especially those implemented in LMIC. This study is funded by the Thai Health Promotion Foundation and National Alliance for Tobacco-Free Thailand.

This study is funded by the Thai Health Promotion Foundation and National Alliance for Tobacco-Free Thailand.

The impact of Thai multidisciplinary smoking cessation program on clinical outcomes: A multicentre prospective observational study
Chayutthaphong Chaisai, Kednapa Thavorn, Somkiat Wattanasirichaigoon, Suthat Rungruanghiranya, Araya Thongphiew, Piyameth Dilokthornsakul, Shaun Lee, Nathorn Chaiyakunapruk
Frontiers in Public Health
Cost-effectiveness analysis of the SMART quit clinic program in smokers with cardiovascular disease in Thailand
Alyssa Grant, Chia Tan, Somkiat Wattanasirichaigoon, Suthat Rungruanghiranya, Araya Thongphiew, Kednapa Thavorn, Nathorn Chaiyakunapruk
Tobacco Induced Diseases
Journals System - logo
Scroll to top